Clinical Trials Logo
  1. Home
  2. Infantile Hemangioma
  3. NCT02913612

Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) — TIM01  

Infantile Hemangioma Clinical Trial

Official title:
Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH)

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of Timolol 0.25% and 0.5% doses.

Clinical Trial Description

Primary: Describe the efficacy of 0.25% and 0.5% topical timolol maleate Gel-forming solution (GFS) as assessed through Infantile Hemangioma (IH) changes in volume. Secondary: Describe the safety of topical timolol maleate GFS for treatment of IH. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02913612
Study type Interventional
Source Duke University
Contact
Status Completed
Phase Phase 2
Start date May 5, 2017
Completion date October 20, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02505971 - Nadolol Versus Propranolol in Children With Infantile Hemangiomas Phase 3
Recruiting NCT04288700 - Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma Phase 4
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT01010308 - Nadolol for Proliferating Infantile Hemangiomas Phase 2
Completed NCT01673971 - Optical Tomographic Imaging of Infantile Hemangiomas
Recruiting NCT03237637 - Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas Phase 3
Recruiting NCT05479123 - Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas Phase 4
Terminated NCT01434849 - Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial) Phase 1
Completed NCT04105517 - Hemangiol, Post Marketing Surveillance Study
Completed NCT01512173 - Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo Phase 2
Completed NCT01056341 - Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy Phase 2/Phase 3
Not yet recruiting NCT04684667 - ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" Phase 2
Recruiting NCT03842631 - Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
Recruiting NCT03173352 - A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China N/A